Tata Elxsi, Terumo Launch Offshore Development Centre in Pune to Advance Cardiac and Vascular Technologies
The newly inaugurated Terumo–Tata Elxsi Offshore Development Center will support end-to-end development of medical devices, including design, engineering, verification, regulatory compliance and lifecycle management for global markets.
Pune-based centre to leverage AI, engineering and regulatory expertise for global medical device innovation
Pune: Tata Elxsi has partnered with Japan-based Terumo Corporation to launch a global offshore development centre (ODC) in Pune, aimed at accelerating innovation in cardiac and vascular medical technologies.
The newly inaugurated Terumo–Tata Elxsi Offshore Development Center will support end-to-end development of medical devices, including design, engineering, verification, regulatory compliance and lifecycle management for global markets.
Focus on next-generation healthcare innovation
The centre brings together multidisciplinary teams to work on patient-centric medical technologies, leveraging Tata Elxsi’s capabilities in software engineering, design and regulatory frameworks.
The collaboration will also integrate artificial intelligence (AI), generative AI (GenAI) and digital technologies to accelerate product development, improve cost efficiency and enable faster adaptation for different markets.
Strengthening global product development capabilities
Fumihisa Hirose, president of the cardiac and vascular company at Terumo Corporation, said the partnership would enhance the company’s ability to innovate and scale globally.
“This new Offshore Development Center strengthens our ability to innovate faster and deliver high-quality medical technologies across global markets,” he said.
Sreevatsa Sahasranaman, senior vice president and head of healthcare and life sciences at Tata Elxsi, said the centre represents a long-term collaboration focused on innovation and efficiency.
“This Offshore Development Center represents a comprehensive long-term partnership model to drive innovation and cost efficiencies across Terumo’s cardiovascular portfolio,” he said.
Enhancing reliability and global access
The partnership is expected to improve the reliability, performance and global availability of cardiac and vascular technologies, while ensuring compliance with international regulatory standards.
By combining engineering, design and regulatory expertise, the centre aims to support the development of next-generation medical devices tailored to evolving healthcare needs.
Expanding India’s role in global medtech ecosystem
Industry observers note that such offshore development centres are increasingly positioning India as a key hub for global medical technology innovation, driven by talent availability, cost advantages and growing expertise in healthcare engineering.
Tata Elxsi, headquartered in Bengaluru, provides design and technology services across sectors including healthcare, automotive and communications, and collaborates with global medical device companies on advanced product development.
The initiative reflects a broader trend of global healthcare firms leveraging India-based innovation ecosystems to accelerate development and improve access to advanced medical technologies worldwide.
